Bodhi Tree Biotechnology Inc. Files Corrected Form 8-K with SEC

Strategic Insights -

Bodhi Tree Biotechnology Inc., a biotechnology company, has filed a corrected Form 8-K with the U.S. Securities and Exchange Commission (SEC) on June 6, 2025, following an immaterial inaccuracy in its initial registration statement on Form S-1. The company disclosed that 55 accredited investors participated in a private placement transaction, but the correct number is 29. Additionally, the company had initially reported 29 non-accredited investors in a private placement transaction, when in fact, no non-accredited investors participated.

Key Takeaways:

  • Bodhi Tree Biotechnology Inc. filed a corrected Form 8-K with the SEC on June 6, 2025, to correct an immaterial inaccuracy in its initial registration statement on Form S-1.
  • The company disclosed that 55 accredited investors participated in a private placement transaction, but the correct number is 29.
  • The company initially reported 29 non-accredited investors in a private placement transaction, which was an error, as no non-accredited investors participated.
  • The corrected filing was made on June 5, 2025, and the company has ensured that all necessary disclosure has been provided to investors.
  • This corrected filing is in accordance with the requirements of the Securities Exchange Act of 1934.

Statistics:

  • 29 accredited investors participated in the private placement transaction (as corrected in the Form 8-K filing).
  • 55 was the incorrect number of accredited investors reported in the initial registration statement on Form S-1.
  • 0 non-accredited investors participated in the private placement transaction (as corrected in the Form D filing).

Sources:

  • UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT
  • Bodhi Tree Biotechnology Inc. (Exact name of registrant as specified in its charter), Form 8-K filing dated June 5, 2025.